🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07603011
Recruiting Observational

Effect of Catheter Duration on Prostate Laser Enucleation Surgery Outcomes in Patients With Urinary Retention

NCT07603011 · tracked via the Priya Life Science Turkey tracker
Sponsor
Eskişehir Osmangazi University Medicine Faculty Hospital
Phase
Observational
Started
2026-02-04
Last updated
2026-09-11

Condition(s) studied

Urinary RetentionBenign Prostate Obstruction (BPO)

Investigational drug(s) / intervention(s)

Laser Enucleation of the Prostate (HoLEP, ThuLEP, ThuFLEP)

Laser Enucleation of the Prostate (HoLEP, ThuLEP, ThuFLEP): Patients undergo endoscopic laser enucleation of the prostate using either Holmium or Thulium laser platforms, depending on the standard equipment and clinical preference of the participating center. The procedure involves the anatomical enucleation of the prostatic adenoma from the surgical capsule, followed by intravesical morcellation of the enucleated tissue. All surgeries are performed by urologists according to established surgical protocols.

Study summary

Benign Prostatic Obstruction (BPO) is a common condition in aging men that can lead to urinary retention, often requiring the use of an indwelling urinary catheter. While laser enucleation of the prostate (such as HoLEP, ThuLEP or ThuFLEP) is a safe and effective surgical treatment, it is not well understood how the length of time a patient spent with a urethral catheter before surgery affects the final surgical outcomes. By analyzing patient data from multiple centers of the Minimally Invasive Urology Society, this study aims to evaluate the impact of preoperative catheterization duration on functional outcomes.

Eligibility

Sex
MALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients undergoing laser enucleation of the prostate, including HoLEP, ThuLEP or ThuFLEP procedures, who have an indwelling urinary catheter due to pre-operative urinary retention. Exclusion Criteria: * Patients with a diagnosis of neurogenic bladder or prostate cancer.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Eskisehir Osmangazi University, Faculty of Medicine, Department of Urology Eskişehir Eskişehir Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07603011 on ClinicalTrials.gov ↗ ← All trials in Turkey